CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Search

We found 6932 result(s)

Vancomycin Therapeutic Drug Monitoring

Last Updated: July 16, 2020
Result type: Reports
Product Line: Technology Review

There has been a long-standing controversy as to which method is preferable for the optimal dosing of vancomycin administered IV; i.e., only measuring trough blood levels or calculating the ratio of area under the curve (AUC) over the course of 24 hours to the minimum inhibitory concentration (AUC/MIC). Recently, the 2020 US guidelines on the th...

  • Project Number: HA0006-000

vedolizumab (Entyvio )

Last Updated: July 13, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: vedolizumab
Indications: Ulcerative Colitis

  • Brand Name: Entyvio
  • Manufacturer: Takeda Canada Inc.
  • Project Number: SR0635-000
  • Project Status: Complete
  • Submission Type: New

sacubitril/valsartan (Entresto)

Last Updated: July 10, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: sacubitril/valsartan
Indications: Heart failure, NYHA Class II or III

  • Brand Name: Entresto
  • Manufacturer: Novartis Pharma Inc.
  • Project Number: SR0644-000
  • Project Status: Active
  • Submission Type: Resubmission

burosumab (Crysvita)

Last Updated: November 28, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: burosumab
Indications: Treatment of X-Linked Hypophosphatemia

  • Brand Name: Crysvita
  • Manufacturer: Kyowa Kirin Limited
  • Project Number: SR0602-000
  • Project Status: Complete
  • Submission Type: New